KCM
NAMS icon

Kornitzer Capital Management’s NewAmsterdam Pharma NAMS Stock Holding History

Kornitzer Capital Management’s Portfolio NAMS Stock Details NAMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.74M Buy
+139,933
New +$4.61M 0.1% 201

Other funds holding NAMS

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
MMC
Mizuho Markets Cayman Grand Cayman, Cayman Islands $2.67B AUM 103.47% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
MAP
Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

Kornitzer Capital Management's NAMS Position: Q2 2026 in Review

Kornitzer Capital Management opened a new position in NewAmsterdam Pharma (NAMS) in Q2 2026: 139,933 shares worth $4.74M. The stake represents 0.1% of the portfolio and ranks #201 among its holdings.

31 funds tracked by Wall St. Rank hold NAMS as of Q2 2026.

  • Kornitzer Capital Management held 139,933 shares of NewAmsterdam Pharma worth $4.74M as of Q2 2026.
  • NewAmsterdam Pharma was a new Kornitzer Capital Management position in Q2 2026.
  • NewAmsterdam Pharma made up 0.1% of Kornitzer Capital Management's portfolio in Q2 2026, its #201 holding.
  • 31 funds tracked by Wall St. Rank held NewAmsterdam Pharma as of Q2 2026.

Based on Kornitzer Capital Management's 13F filing for Q2 2026, filed 31 Jul 2026.